Evidence map›Paper›PMID 26393018›Full record

ArticlePublic health action2013

Does the type of treatment supporter influence tuberculosis treatment outcomes in Zimbabwe?

N Mlilo, C Sandy, A D Harries, A M V Kumar, N Masuka, B Nyathi, M Edginton, P Isaakidis, M Manzi, N Siziba

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Public health action, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Family directly observed therapy for children with drug-resistant TB.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

N MliloInternational Union Against Tuberculosis and Lung Disease (The Union), Harare, Zimbabwe.
C SandyNational Tuberculosis Control Programme, Harare, Zimbabwe.
A D HarriesThe Union, Paris, France ; London School of Hygiene & Tropical Medicine, London, United Kingdom.
A M V KumarThe Union, New Delhi, India.
N MasukaMinistry of Health and Child Welfare, Matabeleland, North Province, Zimbabwe.
B NyathiInternational Union Against Tuberculosis and Lung Disease (The Union), Harare, Zimbabwe.
M EdgintonEthics Advisory Group, The Union, Paris, France.
P IsaakidisMédecins Sans Frontières-Luxembourg, Luxembourg.
M ManziMédecins Sans Frontières-Luxembourg, Luxembourg.
N SizibaNational Tuberculosis Control Programme, Harare, Zimbabwe.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zimbabwe National Tuberculosis Guidelines advise that direct observation of anti-tuberculosis treatment (DOT) can be provided by a family member/relative as a last resort. In 2011, in Nkayi District, of 763 registered tuberculosis (TB) patients, 59 (8%) received health facility-based DOT, 392 (51%) received DOT from a trained community worker and 306 (40%) from a family member/relative. There were no differences in TB treatment outcomes between the three DOT groups, apart from a higher frequency rate of 'no reported outcomes' for those receiving family-based DOT. Family members should be trained to use a suitable DOT support package.

Indexed as

DOToperational researchtreatment outcomestreatment supportertuberculosisZimbabwe

Identifiers

PMID26393018
PMCPMC4463109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.